CLOUGH CAPITAL PARTNERS L P - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 94 filers reported holding GOSSAMER BIO INC in Q4 2019. The put-call ratio across all filers is 13.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q2 2021$1,297,000
-69.4%
159,725
-65.2%
0.07%
-62.4%
Q1 2021$4,242,000
-4.6%
458,634
-0.3%
0.19%
-40.2%
Q4 2020$4,447,000
-22.1%
459,8340.0%0.32%
-22.9%
Q3 2020$5,707,000
-4.5%
459,8340.0%0.41%
-29.9%
Q2 2020$5,978,000
+28.1%
459,8340.0%0.58%
+26.1%
Q1 2020$4,667,000
-35.1%
459,8340.0%0.46%
-24.3%
Q4 2019$7,187,000
-12.9%
459,834
-6.5%
0.61%
-10.2%
Q3 2019$8,256,000
-16.7%
491,734
+9.3%
0.68%
-29.7%
Q2 2019$9,915,000
-2.7%
449,934
-6.3%
0.97%
+9.1%
Q1 2019$10,189,000480,2340.89%
Other shareholders
GOSSAMER BIO INC shareholders Q4 2019
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 1,513,138$19,020,0004.68%
Omega Fund Management, LLC 3,320,608$41,740,0004.68%
Ally Bridge Group (NY) LLC 1,175,000$14,770,0004.34%
Parkman Healthcare Partners LLC 786,870$9,891,0002.50%
Palo Alto Investors LP 1,772,950$22,286,0001.34%
HHLR ADVISORS, LTD. 7,420,974$93,282,0001.22%
Ikarian Capital, LLC 1,351,933$16,995,0001.20%
Boxer Capital, LLC 2,462,358$30,952,0001.08%
ACUTA CAPITAL PARTNERS, LLC 215,000$2,703,0000.95%
EMERALD ADVISERS, LLC 1,516,003$19,056,0000.69%
View complete list of GOSSAMER BIO INC shareholders